Your browser doesn't support javascript.
loading
HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis.
Mou, Jiahui; Huang, Meijun; Wang, Feifei; Xu, Xiaoding; Xie, Hanqi; Lu, Henglei; Li, Mingyang; Li, Yu; Kong, Weiwen; Chen, Jing; Xiao, Ying; Chen, Yiding; Wang, Chaochen; Ren, Jin.
Affiliation
  • Mou J; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Huang M; University of Chinese Academy of Sciences, Beijing, China.
  • Wang F; ZJU-UoE Institute, Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining, Zhejiang, China.
  • Xu X; Nanjing University of Chinese Medicine, Nanjing, China.
  • Xie H; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Lu H; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
  • Li M; ZJU-UoE Institute, Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining, Zhejiang, China.
  • Li Y; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Kong W; ZJU-UoE Institute, Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining, Zhejiang, China.
  • Chen J; Department of Breast Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xiao Y; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Chen Y; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wang C; Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Ren J; University of Chinese Academy of Sciences, Beijing, China.
Mol Cancer Res ; 20(12): 1724-1738, 2022 12 02.
Article in En | MEDLINE | ID: mdl-36066963
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / HMGN Proteins Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / HMGN Proteins Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: